Search Results - "Aydin, Seniz Ongoren"

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia by Eskazan, Ahmet Emre, Elverdi, Tugrul, Yalniz, Fevzi Firat, Salihoglu, Ayse, Ar, Muhlis Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman

Get full text

Two leptospirosis cases presented with fever, anemia, and hepatosplenomegaly by Polat, Erdal, Özdemir, Sebati, Öngören Aydın, Şeniz, Aydın, Ahmet

Get full text

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy by Eskazan, Ahmet Emre, Hatemi, İbrahim, Öngören Aydın, Seniz, Ar, Muhlis Cem, Soysal, Teoman

Get full text

Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options by Çetin, Güven, Eşkazan, Ahmet Emre, Ar, M Cem, Aydın, Şeniz Öngören, Ferhanoğlu, Burhan, Soysal, Teoman, Başlar, Zafer, Aydın, Yıldız

“…This study aimed to investigate the impact of the different therapy regimens used in multiple myeloma (MM) on bone-specific alkaline phosphatase (BALP) levels…”
Get full text

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate by Eskazan, Ahmet Emre, Ayer, Mesut, Kantarcioglu, Bulent, Arica, Deniz, Demirel, Naciye, Aydin, Demet, Yalniz, Fevzi Firat, Elverdi, Tugrul, Salihoglu, Ayse, Ar, Muhlis Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman

Get full text

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion by Eskazan, Ahmet Emre, Eyice, Deniz, Kurt, Enes Ali, Elverdi, Tugrul, Yalniz, Fevzi Firat, Salihoglu, Ayse, Ar, Muhlis Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Ferhanoglu, Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman

“…Abstract Dasatinib is a potent second generation TKI, and it is widely used in patients with CML, both in the up-front setting and failure after imatinib…”
Get full text

Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia by Tanrikulu Simsek, Eda, Eskazan, Ahmet Emre, Cengiz, Mahir, Ar, Muhlis Cem, Ekizoglu, Seda, Salihoglu, Ayse, Gulturk, Emine, Elverdi, Tugrul, Ongoren Aydin, Seniz, Senem Demiroz, Ahu, Buyru, Ayse Nur, Baslar, Zafer, Ozbek, Ugur, Ferhanoglu, Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Soysal, Teoman

“…Before the era of tyrosine kinase inhibitors (TKIs), the presence of bone marrow fibrosis (MF) in patients with chronic myeloid leukaemia (CML) has been…”
Get more information

Breast schwannoma in a patient with diffuse large B-cell lymphoma: a case report by Salihoglu, Ayse, Esatoglu, Sinem Nihal, Eskazan, Ahmet Emre, Halac, Metin, Aydin, Seniz Ongoren

“…Schwannomas are mostly benign tumors arising from Schwann cells of the nerve sheaths. Breast schwannomas are very rare and account for only 2.6% of cases. As…”
Get full text

Synchronous Detection of Hairy Cell Leukemia and HIV-Negative Kaposi’s Sarcoma of the Lymph Node: A Diagnostic Challenge and a Rare Coincidence by Aydin, Seniz Ongoren, Eskazan, Ahmet Emre, Aki, Hilal, Ozguroglu, Mustafa, Baslar, Zafer, Soysal, Teoman

“…Hairy cell leukemia (HCL) is an uncommon chronic lymphoproliferative disorder and accounts for around 2% of all forms of leukemias. The association of HCL with…”
Get full text

Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature by Soysal, Teoman, Salihoğlu, Ayşe, Esatoğlu, Sinem Nihal, Gültürk, Emine, Eşkazan, Ahmet Emre, Hatemi, Gülen, Hatemi, İbrahim, Öngören Aydın, Şeniz, Erzin, Yusuf Ziya, Başlar, Zafer, Tüzüner, Nükhet, Ferhanoğlu, Burhan, Çelik, Aykut Ferhat

“…Objectives. Behçet’s disease (BD) can be life threatening and may be refractory to corticosteroids and immunosuppressives. There has been some experience with…”
Get full text

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia by Tanrikulu Simsek, Eda, Eskazan, Ahmet Emre, Cengiz, Mahir, Ar, M. Cem, Ekizoglu, Seda, Salihoglu, Ayse, Gulturk, Emine, Elverdi, Tugrul, Ongoren Aydin, Seniz, Demiroz, Ahu Senem, Buyru, Ayse Nur, Baslar, Zafer, Ozbek, Ugur, Ferhanoglu, A. Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Soysal, Teoman

“…Introduction: Imatinib mesylate (IM) is the first tyrosine kinase inhibitor (TKI) licensed for the treatment of chronic myeloid leukemia (CML). Severe bone…”
Get full text

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias by Ozgur Yurttas, Nurgul, Sadri, Sevil, Keskin, Dilek, Berk, Selin, Erdogan Oztunali, Isil, Yalniz, Fevzi Firat, Salihoglu, Ayse, Eskazan, Ahmet Emre, Ar, M. Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Aydin, Yildiz, Soysal, Teoman

“…▪ Background: Drug-induced pulmonary arterial hypertension (PAH) can be observed as an adverse event (AE) during the administration of dasatinib (DAS), which…”
Get full text

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia by Esatoglu, Sinem Nihal, Keskin, Dilek, Kutnu, Muge, Elverdi, Tugrul, Salihoglu, Ayse, Eskazan, Ahmet Emre, AR, Muhlis Cem, Ongoren Aydin, Seniz, Baslar, Zafer, Aydin, Yildiz, Uzun, Hanife, Soysal, Teoman

“…Introduction: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with variable clinical course. Several studies have been conducted to predict…”
Get full text

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance by Erbilgin, Yucel, Eskazan, Ahmet Emre, Ng, Ozden Hatirnaz, Salihoglu, Ayse, Elverdi, Tugrul, Firtina, Sinem, Tatonyan, Suzin Catal, Aydin, Seniz Ongoren, Ar, Muhlis Cem, Baslar, Zafer, Sayitoglu, Muge, Ferhanoglu, A. Burhan, Aydin, Yildiz, Ozbek, Ugur, Soysal, Teoman

“…BCR-ABL1 mutation testing is recommended for chronic myeloid leukemia (CML) patients who have suboptimal response and/or treatment failure with tyrosine kinase…”
Get full text

Ten-Year Follow-up Data of Diffuse Large B-Cell Lymphoma Patients: Single Center Experience by Ozbalak, Murat, Ar, M. Cem, Salihoglu, Ayse, Gulturk, Emine, Eskazan, Ahmet Emre, Ongoren Aydin, Seniz, Baslar, Zafer, Soysal, Teoman, Aydin, Yildiz, Tuzuner, Nukhet, Ferhanoglu, A. Burhan

“…Abstract 5223 Non-Hodgkin's Lymphoma (NHL) is the most common type of hematopoietic cancers and it constitutes 4% of all cancers. It is the seventh most common…”
Get full text

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia by Eskazan, Ahmet Emre, Tatonyan, Suzin Catal, Salihoglu, Ayse, Gulturk, Emine, Ar, M. Cem, Aydin, Seniz Ongoren, Baslar, Zafer, Ferhanoglu, A. Burhan, Tuzuner, Nukhet, Aydin, Yildiz, Ozbek, Ugur, Soysal, Teoman

“…Abstract 1692 There has been a remarkable improvement in the management of chronic myeloid leukemia (CML) after imatinib mesylate (IM) became available in the…”
Get full text

CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia by Sevinc, Mustafa, Eskazan, Ahmet Emre, Karabulut, Aydin, Tatonyan, Suzin Catal, Gulturk, Emine, Salihoglu, Ayse, Aydin, Seniz Ongoren, Ar, M. Cem, Baslar, Zafer, Ferhanoglu, A. Burhan, Tuzuner, Nukhet, Aydin, Yildiz, Ozbek, Ugur, Soysal, Teoman

“…Abstract 4603 Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in the Western world with an annual incidence of 5/100,000. The clinical course…”
Get full text

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience by Alp, Suzan, Salihoglu, Ayse, Eskazan, Ahmet Emre, Gulturk, Emine, Ar, M. Cem, Aydin, Seniz Ongoren, Baslar, Zafer, Buyru, Ayse Nur, Ozbek, Ugur, Ferhanoglu, A. Burhan, Aydin, Yildiz, Soysal, Teoman

“…Abstract 4429 Imatinib mesylate (IM) is considered the mainstay of chronic myeloid leukemia (CML) treatment for almost a decade. The primary goal of the study…”
Get full text

Successful Management of Chronic Refractory Immune Thrombocytopenia with Laparoscopic Splenectomy in a Patient with Acute Promyelocytic Leukemia by Eskazan, Ahmet Emre, Salihoglu, Ayse, Gulturk, Emine, Aydin, Seniz Ongoren, Tuzuner, Nukhet, Aydin, Yildiz

“…Acute promyelocytic leukemia (APL) is a particular type of acute myeloid leukemia with characteristic biological and clinical features, the frequent…”
Get full text

The association between JAK2V617F mutation and bone marrow fibrosis at diagnosis in patients with philadelphia-negative chronic myeloproliferative neoplasms / Philadelphia Negatif kronik Miyeloproliferatif Neoplazili Hastalarin Tanisinda JAK2V617F mutasyonu ile Kemik Iligindeki Fibrozun Iliskisi by Cem Ar, M, Buyuktas, Deram, Eskazan, A. Emre, Aydin, Seniz Ongoren, Tanrikulu, Eda, Baslar, Zafer, Buyru, A.Nur, Ferhanoglu, Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Soysal, Teoman

Get full text